Related Articles
DIFFERENT PATTERNS OF P53 GENE-MUTATIONS IN ENDOMETRIAL CARCINOMAS AND ENDOMETRIOID CARCINOMAS OF THE OVARY
Genetic pathways of ‘de novo’ colorectal carcinomas with reference to fetal-type glycogen phosphorylase positive foci
Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma
Analysis of the K-ras/B-raf/Erk signal cascade, p53 and CMAP as markers for tumor progression in colorectal cancer patients
Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: A case-control study in Taiwan